Work

Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy

Year: 2026

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.5c03487

Authors: Long Zheng, Yiwei Zheng, Sijie Wu, Yonglei Zhang, Zhongwen Luo, Yuhan Jiang, Shunxin Guo, Meiting Zou, Lingyi Kong, Xiaobing Wang

Institution: China Pharmaceutical University

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Higher Education Discipline Innovation Project, “333 Project” of Jiangsu Province

Awards: G533960073, G8182218573

OpenAlex ID: W7133704588

FWCI: 3.684

Cites: 40

Cited by: 2

Related to: